Erratum zu: CRIMSON
- PMID: 41498924
- DOI: 10.1007/s00347-025-02373-w
Erratum zu: CRIMSON
Erratum for
-
[CRIMSON : A multicentre randomised, sham-controlled, double-masked, 72-week trial to study the safety, tolerability, pharmacokinetics, and efficacy of 3 dosing regimens of intravitreal BI 764524 in patients with moderate to severe non-proliferative diabetic retinopathy].Ophthalmologie. 2026 Feb;123(2):123-127. doi: 10.1007/s00347-025-02345-0. Epub 2025 Nov 20. Ophthalmologie. 2026. PMID: 41263999 German. No abstract available.